BioAdapt® Bridge is a DBM-based implant that provides a contoured fit to the bony defect. BioAdapt Bridge provides an open matrix which allows for bony ingrowth, as well as exposure of a full range of proteins known to induce the signal for bone formation.1*
Regulatory approvals vary by country. Therefore, we kindly ask you to contact the distributor in your region regarding availability of specific products, implants and / or instrumentation in your region.
- Cohesive and moldable
- 100% allograft
- Provides a contoured fit to the bony defect
- Can be hydrated with sterile water, saline, autologous blood or BMA
- Large cavity to easily fill with autograft or allograft
- Water insoluble
- Offered in two sizes
- Osteoinductive* potential
*DBM or representative finished implant is either assayed in vivo in the modified athymic nude rat for bone formation or in vitro for endogenous BMP-2 as a surrogate test marker for osteoinductive potential. Because the combination of various proteins is responsible for osteoinductive potential, DBM when assayed in vitro, is also screened for the presence of BMP-7. Findings from an in vitro assay or animal model are not necessarily predictive of human clinical results.
The carrier is sterilized through the BioCleanse® Tissue Sterilization Process and the DBM is sterilized through the Cancelle SP® DBM Sterilization Process, which was specifically designed to preserve protein activity.